Given the strong etiological link between Epstein-Barr virus (EBV) and NPC, EBV-encoded proteins such as LMP1, LMP2 and EBNA1 have been used as vaccine targets for NPC. The gene discussed is PSMB9; the disease is nasopharyngeal carcinoma.